Unique workshops organised with EORTC & EMA
22 February 2024
The European Organisation for Research and Treatment of Cancer (EORTC) has joined forces with the European Medicines Agency (EMA) to organise an extraordinary series of workshops addressing the many challenges of clinical research, from ultra-rare cancers to quality of life and treatment optimisation.
The three workshops take place in the first half of 2024 in Amsterdam:
1) The EMA/EORTC multi-stakeholder workshop on soft tissue and bone sarcoma (12 January)
2) The EMA/EORTC workshop: “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?” (29 February)
3) The Cancer Medicines Forum workshop (5 April)
Find out more and register here.
